Prolactinoma clinical trials

Explore recruiting prolactinoma clinical trials.

Recruiting prolactinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prolactinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

18F-fluoro-ethyl-tyrosine (18FET) PET for difficult clinical situations in functional pituitary adenoma. A prospective, single arm, single center study. (FET-PIT)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prolactinoma trials by city

Prolactinoma in Toronto Prolactinoma in Vancouver Prolactinoma in Montreal Prolactinoma in Calgary Prolactinoma in Edmonton Prolactinoma in Ottawa Prolactinoma in Winnipeg Prolactinoma in Quebec City Prolactinoma in Hamilton Prolactinoma in Kitchener Prolactinoma in London Prolactinoma in Halifax Prolactinoma in New York Prolactinoma in Los Angeles Prolactinoma in Chicago Prolactinoma in Houston

Prolactinoma clinical trials

Recruiting prolactinoma studies right now

A Study of Pasireotide in People With Prolactinoma

Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Also recruiting in Europe

18F-fluoro-ethyl-tyrosine (18FET) PET for difficult clinical situations in functional pituitary adenoma. A prospective, single arm, single center study. (FET-PIT)

Prolactinoma trials by city

Other conditions